Aptima HPV E6/E7 mRNA test is as sensitive as Hybrid Capture 2 Assay but more specific at detecting cervical precancer and cancer - Wikidata - awgldk - TriplyDB

Aptima HPV E6/E7 mRNA test is as sensitive as Hybrid Capture 2 Assay but more specific at detecting cervical precancer and cancer

Aptima HPV E6/E7 mRNA test is as sensitive as Hybrid Capture 2 Assay but more specific at detecting cervical precancer and cancer

http://www.wikidata.org/entity/Q34596772

about

Human papillomavirus testing versus repeat cytology for triage of minor cytological cervical lesions Biomarkers of HIV-associated Cancer.The clinical performance of APTIMA human papillomavirus and Hybrid Capture 2 assays in the triage of lesser abnormal cervical cytologies Human papillomavirus testing in primary cervical screening and the cut-off level for hybrid capture 2 tests: systematic review Type-specific human papillomavirus E6/E7 mRNA detection by real-time PCR improves identification of cervical neoplasia.Acceptability and Accuracy of Cervical Cancer Screening Using a Self-Collected Tampon for HPV Messenger-RNA Testing among HIV-Infected Women in South Africa Head-to-Head Comparison of the RNA-Based Aptima Human Papillomavirus (HPV) Assay and the DNA-Based Hybrid Capture 2 HPV Test in a Routine Screening Population of Women Aged 30 to 60 Years in Germany.Human Papillomavirus Assays and Cytology in Primary Cervical Screening of Women Aged 30 Years and Above.Detection of Human Papillomavirus Infections at the Single-Cell Level.Cytology and human papillomavirus testing 6 to 12 months after ASCUS or LSIL cytology in organized screening to predict high-grade cervical neoplasia between screening rounds Comparison of the Abbott RealTime High-Risk Human Papillomavirus (HPV), Roche Cobas HPV, and Hybrid Capture 2 assays to direct sequencing and genotyping of HPV DNA.High-risk human papillomavirus (hrHPV) E6/E7 mRNA testing by PreTect HPV-Proofer for detection of cervical high-grade intraepithelial neoplasia and cancer among hrHPV DNA-positive women with normal cytology Limitations of widely used high-risk human papillomavirus laboratory-developed testing in cervical cancer screening.Human Papillomavirus Laboratory Testing: the Changing Paradigm HPV-based Tests for Cervical Cancer Screening and Management of Cervical Disease.Retrieval of HPV oncogenes E6 and E7 mRNA from cervical specimens using a manual open technology protocol Stability of cervical specimens in SurePath medium for human papillomavirus testing with the Roche cobas 4800 assay.The Aptima HPV assay fulfills the cross-sectional clinical and reproducibility criteria of international guidelines for human papillomavirus test requirements for cervical screening Disagreement between human papillomavirus assays: an unexpected challenge for the choice of an assay in primary cervical screening.Comparison of commercial hybridization and automated transcription-mediated amplification modalities for detection of high-risk human papillomavirus nucleic acid.Effect of preanalytical processing of ThinPrep specimens on detection of high-risk human papillomavirus by the Aptima HPV assay.Testing for human papillomavirus in cervical cancer screening: a review of indications and methodology.Human papillomavirus testing and genotyping in cervical screening.The APTIMA HPV assay versus the Hybrid Capture 2 test in triage of women with ASC-US or LSIL cervical cytology: a meta-analysis of the diagnostic accuracy.Triage of women with minor abnormal cervical cytology: meta-analysis of the accuracy of an assay targeting messenger ribonucleic acid of 5 high-risk human papillomavirus types.Understanding HPV tests and their appropriate applications.FHACT: the FISH-based HPV-associated cancer test that detects nonrandom gain at four genomic loci as biomarkers of disease progression.Determinants of Viral Oncogene E6-E7 mRNA Overexpression in a Population-Based Large Sample of Women Infected by High-Risk Human Papillomavirus Types.Molecular approaches for HPV genotyping and HPV-DNA physical status.Current and Emerging Molecular Tests for Human Papillomavirus-Related Neoplasia in the Genomic Era.Referral population studies underestimate differences between human papillomavirus assays in primary cervical screening.Sensitivity of APTIMA HPV E6/E7 mRNA test in comparison with hybrid capture 2 HPV DNA test for detection of high risk oncogenic human papillomavirus in 396 biopsy confirmed cervical cancers.HPV E6/E7 mRNA versus HPV DNA biomarker in cervical cancer screening of a group of Macedonian women.Prospective evaluation of E6/E7 mRNA detection by the NucliSENS Easy Q HPV assay in a stepwise protocol.Performance of ProEx C and PreTect HPV-Proofer E6/E7 mRNA tests in comparison with the hybrid capture 2 HPV DNA test for triaging ASCUS and LSIL cytology.Evaluation of p16(INK4a)/Ki-67 dual stain in comparison with an mRNA human papillomavirus test on liquid-based cytology samples with low-grade squamous intraepithelial lesion.Effectiveness of HPV 16 viral load and the E2/E6 ratio for the prediction of cervical cancer risk among Chinese women.E6/E7 proteins are potential markers for the screening and diagnosis of cervical pre-cancerous lesions and cervical cancer in a Chinese population.Stability, integrity, and recovery rate of cellular nucleic acids preserved in a new liquid-based cytology medium.HPV genotype determination and E6/E7 mRNA detection for management of HPV positive women.

P2860

Q24198236-A31FF7A5-1BB7-4E82-A798-80F0EF0CF707 Q33856851-622DA74A-D0EB-4D0F-80F8-E24A9A9E4F51 Q34330297-EE99F73F-59C6-432E-B0B0-FA3C52373309 Q34997580-3CC065BE-A25D-4224-B74D-59F531C4A8E7 Q35530550-E71F383E-A430-45C0-95A8-42647DCF5EE9 Q35762277-8386EF85-597E-470C-8D07-F0E58EBBBDF8 Q35868702-40B04E98-040B-4BDF-B9EE-E38D7C6B7ABB Q35898888-3F38890E-2797-476B-BC61-1A77A2F0392E Q35907151-0E3C0819-E912-4A06-B2FF-F38D3A47A7A7 Q36023019-D2E55191-ED03-4810-9418-7F9F21437964 Q36118559-316873C9-5F22-4AA4-9CD4-245AF8C562C5 Q36118590-52439077-E6B4-4CED-9FCC-8314412D8C51 Q36395656-B0267BBF-F53F-478B-B516-4DD069D4BB66 Q36675236-EEA08B30-3A42-4B72-9A69-065202211A66 Q36856284-0AFC21DF-4BA6-4B21-B25C-B962DF221B6E Q37225996-40B13F05-3072-4F2B-A731-B45F277101C7 Q37264271-4E3ADEF7-9130-4C76-9037-1D7412754CBD Q37470374-46800BC1-E564-400E-A672-42914F7E2DF2 Q37496183-0E31270F-3F3C-4BAC-929C-42CC8CC38BF9 Q37546570-80702F7C-2DA6-4319-8C41-512569D0A75D Q37713738-F414B174-0193-4943-88AD-945430070905 Q37896031-F353F090-C92D-43A2-9FF7-968064563C29 Q37909359-643AF1D5-EB15-4B47-9329-8FBADECD0A42 Q38011639-D20D0A31-4826-42D3-9374-4272848F72BA Q38123772-6FACD2ED-CF7E-4DCC-9211-775FAF141171 Q38133612-50F051A4-43C3-497D-ACBE-081D2F1725E7 Q38259453-C9F761D9-5333-4CF5-AFF8-25D12B21F778 Q39013857-F4F3D09A-D8C1-4F9B-9862-43974FD701A9 Q39120200-8FD11578-75E0-4089-9CEE-20BB8AE8BA2B Q39191687-2B89B846-EA3D-4BD3-B0A8-62B6232AE51A Q40043990-486A1D2A-63F3-46B9-948C-A483FECE6B75 Q40861259-E1A45A52-AF0A-4F4C-838D-1AF0DACCD851 Q41328485-2B768F4E-726C-4DE7-BD0C-3EE7F868EAFA Q42278781-1AABC7F1-27B0-4DE0-8409-B8EBC5BD7633 Q43524242-96615E8A-9AA6-4C9C-A9E5-6704863B1182 Q44451879-E2B50DDB-0DD2-40D1-8E82-0839D7265CE4 Q45903948-0DBAAA12-40F9-4F5A-AF25-BD5D8B8F96EE Q47113153-6C1C77DA-007D-4ACB-99F7-0A2CC72B5C98 Q48227578-18C31159-FB35-4BA2-B9A2-C176B6131E60 Q54247283-CDC9D410-610E-42B7-BAE5-F575A7234E4B

P2860

Aptima HPV E6/E7 mRNA test is as sensitive as Hybrid Capture 2 Assay but more specific at detecting cervical precancer and cancer

http://www.wikidata.org/entity/Q34596772

description

2010 nî lūn-bûn

@nan

2010 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի դեկտեմբերին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Aptima HPV E6/E7 mRNA test is ...... cervical precancer and cancer

@ast

Aptima HPV E6/E7 mRNA test is ...... cervical precancer and cancer

@en

Aptima HPV E6/E7 mRNA test is ...... cervical precancer and cancer

@nl

type

label

Aptima HPV E6/E7 mRNA test is ...... cervical precancer and cancer

@ast

Aptima HPV E6/E7 mRNA test is ...... cervical precancer and cancer

@en

Aptima HPV E6/E7 mRNA test is ...... cervical precancer and cancer

@nl

prefLabel

Aptima HPV E6/E7 mRNA test is ...... cervical precancer and cancer

@ast

Aptima HPV E6/E7 mRNA test is ...... cervical precancer and cancer

@en

Aptima HPV E6/E7 mRNA test is ...... cervical precancer and cancer

@nl

P1433

Q34596772-DC43F6CB-DE39-4B41-AFAC-E3B838A97D73

P1476

Q34596772-8F5270D9-219D-406B-9952-19A2620B2104

P2093

Q34596772-4672E351-8604-4551-BC0E-D7AEB502B4A3

Q34596772-5E6F92F3-64CB-4D75-933B-A67B759D514C

Q34596772-61074CE1-8C65-4B4C-B530-52924AA3495F

Q34596772-6B3476A7-3D1D-4242-ABA0-C5955AD01692

Q34596772-8F230620-42A1-439E-87C8-3907493588ED

Q34596772-B1C0DC1F-F5BF-47BD-8B32-5A55088BBA95

Q34596772-B35CE7E4-D8BD-4EE3-A4A1-1D773828929C

Q34596772-BBAB241A-4AAE-4FD9-834A-67F5D069ED1A

Q34596772-C462503D-BA5E-4445-90DE-39E1286A586D

Q34596772-C52AF38C-33EF-4807-802B-D97B3BAB1DB9

P2860

Q34596772-07837BCB-A0B2-4E57-85CD-A7C2A01E7E60

Q34596772-0E8BE436-E5FF-488B-8AB9-507FB2259D94

Q34596772-1194DF24-CDC6-423B-8185-9E67DA3FD1F4

Q34596772-15C9F25A-1655-4AC2-B733-3EBE12375F8B

Q34596772-19295282-738C-446C-90C1-EFB810F3041A

Q34596772-1A015814-DABC-44D7-AC4B-30B0302143F9

Q34596772-1F8FCBFC-97AF-4866-9482-D2F93C789B4B

Q34596772-29785FA2-4964-4A6E-BFA9-AB6BF3778011

Q34596772-2EA5A275-7010-4448-AECA-EBAFD29AA265

Q34596772-2EC1D1E2-F92E-4F35-BFE7-71FC72C7CC88

P304

Q34596772-BCE12FDB-FFF6-4A45-B533-D3EFB8894E7C

P31

Q34596772-000B5F09-C0FA-4305-8E64-F6C2529E6B28

P356

Q34596772-B81B108C-3B77-4F51-A7FE-4CF86DE7A8A1

P407

Q34596772-8865B15B-F4E2-465A-86A8-9DA6C1262D54

P433

Q34596772-AA92CCE8-BC8C-4061-ABDB-30A82AD12A62

P478

Q34596772-165EADB7-4D4F-4D45-8092-153F0EA2B8B5

P577

Q34596772-AA0BE5C8-2247-4317-B55F-4BC9D75722D8

P698

Q34596772-CAB357CC-1D0A-4E51-88B2-CF7AEDB4CE51

P932

Q34596772-7AAA5B95-7489-4D1D-9E7F-FFEF7A34FBBA

P356

P1433

Journal of Clinical Microbiology

P1476

Aptima HPV E6/E7 mRNA test is ...... cervical precancer and cancer

@en

P2093

Adrian Lear

http://www.w3.org/2001/XMLSchema#string

Christopher Giede

http://www.w3.org/2001/XMLSchema#string

Dan Fontaine

http://www.w3.org/2001/XMLSchema#string

Elias Bartellas

http://www.w3.org/2001/XMLSchema#string

Francois Coutlee

http://www.w3.org/2001/XMLSchema#string

Glen Holloway

http://www.w3.org/2001/XMLSchema#string

James Bentley

http://www.w3.org/2001/XMLSchema#string

Nicholas Escott

http://www.w3.org/2001/XMLSchema#string

Nick Kum

http://www.w3.org/2001/XMLSchema#string

Prafull Ghatage

http://www.w3.org/2001/XMLSchema#string

P2860

2006 consensus guidelines for the management of women with cervical intraepithelial neoplasia or adenocarcinoma in situ

Epidemiology and natural history of human papillomavirus infections and type-specific implications in cervical neoplasia

A review of human carcinogens--Part B: biological agents

Human papillomavirus is a necessary cause of invasive cervical cancer worldwide

The expanded use of HPV testing in gynecologic practice per ASCCP-guided management requires the use of well-validated assays.

Clinical performance of the PreTect HPV-Proofer E6/E7 mRNA assay in comparison with that of the Hybrid Capture 2 test for identification of women at risk of cervical cancer.

The 2001 Bethesda System: terminology for reporting results of cervical cytology.

Presence of E6 and E7 mRNA from human papillomavirus types 16, 18, 31, 33, and 45 in the majority of cervical carcinomas.

PreTect HPV-Proofer: real-time detection and typing of E6/E7 mRNA from carcinogenic human papillomaviruses.

Human papillomavirus and Papanicolaou tests to screen for cervical cancer.

P304

557-564

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1128/JCM.02147-10

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

49

http://www.w3.org/2001/XMLSchema#string

P577

2010-12-08T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

21147950

http://www.w3.org/2001/XMLSchema#string

P932

3043526

http://www.w3.org/2001/XMLSchema#string